- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01129089
Acceptability of Nutrient Supplements Among Women and Children in Bangladesh
September 20, 2024 updated by: University of California, Davis
Acceptability of Lipid-based Nutrient Supplements (LNS) and Micronutrient Powder (MNP) for Women and Infants in Bangladesh
The study aims to confirm the acceptability of lipid-based nutrient supplements (LNS) for use as nutritional supplements for pregnant and lactating women (PLW) or infants and young children (IYC) and micronutrient powder (MNP) for use as nutritional supplements for infants and young children in Bangladesh.We hypothesized that at least 75 percent of the test dose of LNS and MNP offered to PLW and IYC will be consumed by them.
Study Overview
Status
Completed
Conditions
Detailed Description
The study will be conducted in three steps.
Step 1 will be a test-feeding to compare the acceptability of each "version" of the LNS-child (LNS-child with cardamom flavor, LNS-child with no added flavor),LNS-PLW (LNS-PLW with cumin flavor, and LNS-PLW with no added flavor) and MNP to the others in terms of taste, smell and texture, as well as amount of the test-dose consumed.
In Step 2, participants in the Phase 1 trial will receive a 2-week supply of one of the LNS products or MNP, which they will consume daily in their homes for 14 days under real-life conditions.
In Step 3, focus group discussions will be held with participants to discuss different aspects of infant and child feeding and discuss best ways for the LNS or MNP product to be used in the context of Bangladesh.
Study Type
Interventional
Enrollment (Actual)
144
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Dinajpur
-
Chirirbandar, Dinajpur, Bangladesh, 5240
- Fatejangpur
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 49 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion criteria for LNS-PLW arm:
- Pregnant women in their second or third trimester (in case of third trimester pregnancy, the expected date of delivery is not within three weeks) or lactating women with a child between 3 days and 6 months of age
- At least 18 years of age
- No life-threatening pregnancy-related complications (e.g., pre-eclampsia, antepartum hemorrhage)
- Apparently healthy and not presently suffering from an acute illness (e.g., fever, diarrhea, acute respiratory tract infection)
- Living in the study area for at least 6 months
- Planning to remain in study area for at least the following three weeks.
Exclusion criteria for LNS-PLW arm:
- Known allergy to peanuts or other food products (as reported on the screening questionnaire)
Inclusion criteria for LNS-Child and MNP-Child arm:
- Children 6-24 months of age
- Consuming solid foods for at least the past 30 days
- Apparently healthy and not presently suffering from an acute illness (e.g., fever, diarrhea, acute respiratory tract infection)
- No known allergy to peanuts or other food products (as reported on the screening questionnaire by the mother/primary caregiver)[LNS-Child only]
- Planning to remain in study area for at least the following three weeks.
Exclusion criteria for LNS-Child and MNP-Child arm:
- Severely malnourished [mid-upper arm circumference (MUAC) < 115 mm]
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: LNS-PLW
There will be 48 pregnant or lactating women (PLW) in this arm.
They will be randomized to receive cumin flavored LNS-PLW or LNS-PLW with no added flavor on day 2. On day 3, the PLW getting a test-dose of cumin flavored LNS-PLW on day 2 will receive LNS-PLW with no added flavor and the PLW getting a test-dose of LNS-PLW with no added flavor on day 2 will receive cumin flavored LNS-PLW.
|
Lipid-based nutrient supplement for pregnant and lactating women
Other Names:
Lipid-based nutrient supplement for infant and young children
Other Names:
|
|
Experimental: LNS-Child
There will be 48 infant and young children(IYC) in this arm.
They will be randomized to receive cardamom flavored LNS-Child or LNS-Child with no added flavor on day 2. On day 3, the IYC getting a test-dose of LNS-Child with no added flavor on day 2 will receive cardamom flavored LNS-Child and the IYC getting a test-dose of cardamom flavored LNS-Child on day 2 will receive LNS-Child with no added flavor.
|
Lipid-based nutrient supplement for pregnant and lactating women
Other Names:
Lipid-based nutrient supplement for infant and young children
Other Names:
|
|
Experimental: MNP-Child
There will be 48 infant and young children(IYC) in this arm.
They will receive MNP on day 2 and day 3.
|
Micronutrient powder for infant and young children
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of test dose consumed
Time Frame: Day 2
|
Mean consumption of the test dose of LNS for PLW, LNS for IYC and MNP for IYC on day 2 (First test dose)
|
Day 2
|
|
Proportion of test dose consumed
Time Frame: Day 3
|
Mean consumption of the test dose of LNS for PLW, LNS for IYC and MNP for IYC on day 3(Second test dose)
|
Day 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of subjects liked the supplements
Time Frame: Day 2
|
Using a five point Likert scale proportion of PLW and IYC liked the supplements will be acertained.
|
Day 2
|
|
Proportion of subjects liked the supplement
Time Frame: Day 3
|
Using a five point Likert scale proportion of PLW and IYC liked the supplements will be acertained.
|
Day 3
|
|
Proportion of subjects liked the supplement
Time Frame: Day 8
|
Using a five point Likert scale proportion of PLW and IYC liked the supplements will be acertained.
|
Day 8
|
|
Proportion of subjects liked the supplement
Time Frame: Day 15
|
Using a five point Likert scale proportion of PLW and IYC liked the supplements will be acertained.
|
Day 15
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Katnryn G Dewey, Ph.D., University of California, Davis
- Study Director: Malay K Mridha, MBBS,MPH, University of Callifornia, Davis
- Study Director: Camila M Chaparro, Ph.D., Academy for Educational Development
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2009
Primary Completion (Actual)
January 1, 2010
Study Completion (Actual)
February 1, 2010
Study Registration Dates
First Submitted
May 13, 2010
First Submitted That Met QC Criteria
May 20, 2010
First Posted (Estimated)
May 24, 2010
Study Record Updates
Last Update Posted (Actual)
September 23, 2024
Last Update Submitted That Met QC Criteria
September 20, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 273918
- 4001-UCD-00 (Other Grant/Funding Number: Food and Nutrition Technical Assistance II (FANTA-2))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malnutrition
-
Mairaj NoorCompletedMalnutrition (Calorie) | Protein-energy MalnutritionPakistan
-
HAN University of Applied SciencesFrieslandCampina; HAS Hogeschool; Centre of Expertise Food (CoE Food); SligroCompletedMalnutrition; Protein | Protein MalnutritionNetherlands
-
Centre hospitalier Henri Mondor d'AurillacNot yet recruitingMalnutrition Severe | Malnutrition; ModerateFrance
-
University of ExeterRecruitingMalnutrition Elderly | Protein MalnutritionUnited Kingdom
-
Erasmus Medical CenterNot yet recruitingMalnutrition or Risk of MalnutritionNetherlands
-
International Centre for Diarrhoeal Disease Research...GlaxoSmithKline; Stanford UniversityCompletedMalnutrition | Malnutrition in Children | Child MalnutritionBangladesh
-
University of Nove de JulhoUnknownMalnutrition, ChildBrazil
-
UNICEFSave the ChildrenCompletedSevere MalnutritionCongo, The Democratic Republic of the
-
Aga Khan UniversityAction Contre la FaimCompletedEvaluation of the Effectiveness and Impact of Community Case Management of Severe Acute MalnutritionSevere MalnutritionPakistan
-
University of California, San FranciscoThrasher Research Fund; Centre de Recherche en Sante de Nouna, Burkina FasoRecruitingAnemia | Malnutrition, Child | Malnutrition, Infant | Hemoglobin Level Measurement | Malnutrition or Risk of MalnutritionBurkina Faso
Clinical Trials on Lipid-based nutrient supplement
-
Tampere UniversityUniversity of California, Davis; Bill and Melinda Gates Foundation; Kamuzu University...Completed
-
University of California, DavisBill and Melinda Gates FoundationCompletedAdherence, TreatmentUnited States
-
Aga Khan UniversityUnited Nations World Food Programme (WFP); Benazir Income Support Programme...Recruiting
-
University GhentInstitut de Recherche en Sciences de la Sante, Burkina Faso; NutrisetCompletedGrowth Retardation | Infant MorbidityBurkina Faso
-
Aga Khan UniversityTrust for Vaccines & Immunization (TVI); Department of Health, Government of... and other collaboratorsCompletedLow Birth Weight | Stunting | Anemia in PregnancyPakistan
-
Pennington Biomedical Research CenterJomo Kenyatta University of Agriculture and TechnologyActive, not recruiting
-
Johns Hopkins Bloomberg School of Public HealthKamuzu University of Health Sciences; United Nations World Food Programme (WFP) and other collaboratorsCompleted
-
University of California, DavisFHI 360Completed
-
University of California, DavisBill and Melinda Gates Foundation; Helen Keller International; Université Polytechnique...Completed
-
International Food Policy Research InstituteHelen Keller InternationalCompleted